Related Experiment Video
Updated: Apr 17, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
The complex relationship between CKD and ambulatory blood pressure patterns
Arjun D Sinha1, Rajiv Agarwal1
1School of Medicine, Indiana University, Indianapolis, IN; and Department of Medicine, Richard L. Roudebush Veterans Administration Medical Center, Indianapolis, IN.
Insights
Ambulatory blood pressure monitoring (ABPM) is crucial for diagnosing nondipping in hypertension patients with chronic kidney disease (CKD). This review examines ABPM
Area of Science:
- Nephrology
- Cardiology
- Hypertension Management
Background:
- Hypertension and chronic kidney disease (CKD) frequently coexist, increasing cardiovascular risks.
- Nondipping, a loss of the normal nighttime blood pressure fall, is diagnosed by ambulatory blood pressure monitoring (ABPM) and is a cardiovascular risk factor.
- CKD is an independent risk factor for nondipping, observed in up to 80% of patients.
Purpose of the Study:
- To review the evidence for using ABPM in CKD patients.
- To examine the link between ABPM patterns and patient outcomes in CKD.
- To assess the evidence for treating nondipping in CKD.
Main Methods:
- Literature review of studies on ABPM in CKD.
- Analysis of evidence linking ABPM-derived hypertension patterns to CKD prognosis.
- Evaluation of treatment strategies for nondipping in the context of CKD.
Main Results:
- ABPM is superior to clinical BP measurement for correlating with end-organ damage and prognosis in CKD.
- Nondipping is highly prevalent in CKD patients.
- Evidence linking nondipping to adverse outcomes in CKD is mixed, necessitating further research.
Conclusions:
- ABPM is a valuable tool for assessing cardiovascular risk in CKD patients.
- Further research is needed to clarify the independent prognostic role of nondipping in CKD.
- Optimizing ABPM use and treatment of nondipping may improve CKD outcomes.
Abstract:
Hypertension and CKD frequently coexist, and both are risk factors for cardiovascular events and mortality. Among people with hypertension, the loss of the normal fall in night-time BP, called nondipping, can only be diagnosed by ambulatory BP monitoring (ABPM) and is a risk factor for cardiovascular events. The pathophysiology of nondipping is complex, and CKD is an independent risk factor for nondipping. In fact, nondipping can be seen in as many as 80% of people with CKD. However, the evidence for nondipping as an independent risk factor or causal agent for adverse outcomes in CKD remains mixed. ABPM has been shown to be superior to clinical BP measurement for correlating with end-organ damage and prognosis in CKD. This review covers the evidence for the use of ABPM in CKD, the evidence linking ABPM patterns to outcome in CKD and the evidence for treatment of nondipping in CKD.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease IV: Nursing Management
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension and Regulation of Blood Pressure

